Is Ginkgo’s synthetic biology story worth $15 billion?

Is Ginkgo’s synthetic biology story worth $15 billion?
The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will transform the manufacture of physical products. What computers did for information, Kelly says, biology will do for the physical world. Instead of making a chemical from petroleum, why not have Ginkgo’s multi-floor…
Read More

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.